“One of the biggest problems in the treatment of depression today is a delay in onset of therapeutic effects”
More than 1 in 10 Americans take antidepressants, but these medications can take weeks—and for some patients, months—before they begin to alleviate symptoms. Now, scientists from the University of Chicago have discovered that selectively blocking a serotonin receptor subtype induces fast-acting antidepressant effects in mice, indicating a potential new class of therapeutics for depression. The work was published Oct. 29 in Molecular Psychiatry.
“One of the biggest problems in the treatment of depression today is a delay in onset of therapeutic effects. There has been a great need to discover faster-acting drugs,” said Stephanie Dulawa, PhD, associate professor of psychiatry and behavioral neuroscience at the University of Chicago and senior author of the study.
Delayed onset of antidepressant therapeutics can significantly impact patients, especially those with major depressive disorder, who often spend months switching between ineffective medications. Currently, only two drugs—ketamine and scopolamine—exhibit rapid onset. Due to severe side effects, however, neither is suitable for human use.
In seeking a new class of fast-acting therapeutics, Dulawa and her team tested biological pathways that had previously been shown to generate antidepressant effects but had never been studied for rate of onset. They looked at different subtypes of serotonin receptors, proteins that are binding partners for serotonin, a neurotransmitter that has been shown to regulate mood, memory and appetite.
Of these subtypes, serotonin 2C receptors stood out. Selectively blocking these receptors in mice significantly reduced depression-like behaviors in only five days, compared to a minimum of two weeks for a control antidepressant medication.
“We observed fast-acting therapeutic effects in multiple behavioral tasks after we administered compounds that selectively block serotonin 2C receptors,” said Mark Opal, a graduate student at the University of Chicago and lead author of the paper. “We began our measurements at five days, but we think there’s a possibility it could be effective even sooner than that.”
Serotonin 2C receptors normally inhibit the release of dopamine, another neurotransmitter commonly associated with mood, from certain neurons. When 2C is blocked, the researchers believe, more dopamine is released into regions of the brain such as the prefrontal cortex. The team also observed the induction of biomarkers that indicate antidepressant action.
This is the first new biological mechanism that has shown the ability to rapidly alleviate symptoms of depression since ketamine and scopolamine, and it potentially represents a much safer alternative.
Go deeper with Bing News on:
- Canzana CBD Oil Reviews-MUST READ! Real Customer Experience!on October 2, 2020 at 7:43 am
Fast acting and instant relief- guaranteed ... of Canzana CBD Oil Here This powerful Canzana CBD oil is formulated for relief from anxiety and depression. It’s also a perfect solution for all joint ...
- New study finds antidepressant drug effective in treating 'lazy eye' in adultson September 30, 2020 at 9:52 am
Subanesthetic ketamine, commonly used to treat depression and pain, evokes rapid and long-lasting antidepressant effects in human patients. There was evidence that ketamine may control how the ...
- UNI Mental Health Serviceson September 30, 2020 at 4:59 am
Our specialists treat conditions like anxiety, eating disorders, major depression, mood disorders ... friends and neighbors safe. From a fast-acting Mobile Crisis Outreach Team to the Warm Line, which ...
- Libido News and Researchon September 27, 2020 at 5:00 pm
fast-acting results. Dr. Hadi Yassine and Dr. Hassan Zaraket In this interview, Dr. Hadi Yassine and Dr. Hassan Zaraket speak about their research into whether COVID-19 will become a seasonal virus.
- Plants over pills: Non-traditional medicine growing in popularity, especially in Colorado’s mountain townson September 24, 2020 at 12:02 pm
She uses the gongs as a pathway to their true feelings, as well as to help them with stress, fear, anxiety, grief or depression. She knows what to play based on what your astrological chart tells her.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- S.F. mental health clinic uses psychedelics to melt away anxietyon October 12, 2020 at 1:04 pm
It's like the tranquilizer and party drug ketamine, but it's FDA approved for depression, and this clinic says its mind-altering effects can lead to new positive ways of thinking.
- Doctors demand end to lockdown as kids as young as 12 on antidepressantson October 11, 2020 at 7:17 pm
Children as young as 12 are being prescribed antidepressants to cope with Melbourne’s COVID-19 lockdown, as doctors plead with Victoria’s Health Minister to lift restrictions now.
- Surprising study that suggests you should take antidepressants... even if you are NOT depressedon October 10, 2020 at 2:06 pm
Dr Saeed Farooq, professor of psychiatry of Keele University suggested using antidepressants to counter depression is akin to taking Aspirin to ward off possible heart disease.
- Is Talking Therapy Failing Women of Colour?on October 9, 2020 at 10:01 pm
Research shows Black, Asian and minority ethnic women are more likely to be diagnosed with a common mental health condition, but less likely to receive treatment ...
- Nonfinancial conflicts of interest can threaten public health: the case of FDA antidepressant warnings and youth suicideson October 7, 2020 at 8:18 am
An undisclosed nonfinancial conflict of interest has kept a black box warning on antidepressants even though the warning is harfmul.